Clincosm LogoSign in Get a demo

Metastatic Castration-resistant Prostate Cancer

Showing 51 - 75 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Castration-resistant Prostate Cancer Trial (Pembrolizumab, Enzalutamide)

Completed
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Aug 16, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (biological, drug, other)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Pembrolizumab 200 mg
  • +11 more
  • Los Angeles, California
  • +30 more
Aug 12, 2022

Radium-223 is and How Well it Works in Chinese Advanced Prostate

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • Multiple Locations, China
    Many locations
Aug 10, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Beijing, China
  • +35 more
Aug 9, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, enzalutamide, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Chengdu, China
  • +7 more
Aug 5, 2022

Metastatic Castration-resistant Prostate Cancer Trial (TmPSMA-02)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • TmPSMA-02
  • (no location specified)
Aug 3, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Tianjin (TABP EIC, Cyclophosphamide, fludarabine)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • TABP EIC
  • +2 more
  • Tianjin, China
    Tianjin pepole's hosptial
Jul 28, 2022

Prostate Cancer, Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in San Francisco

Recruiting
  • Prostate Cancer
  • +2 more
  • Consultation audio recording app
  • San Francisco, California
    University of California, San Francisco
Jul 27, 2022

Metastatic Castration-resistant Prostate Cancer, mCRPC Trial in Melbourne (Cabazitaxel, 177Lu-PSMA-617)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • mCRPC
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
Jul 20, 2022

Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Boston (Talazoparib, Tazemetostat)

Recruiting
  • Metastatic Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
  • +1 more
Jul 18, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (AMG 340)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • AMG 340
  • San Francisco, California
  • +6 more
Jul 14, 2022

Metastatic Castration-resistant Prostate Cancer Trial ([177Lu]Ludotadipep 3.7 GBq)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • [177Lu]Ludotadipep 3.7 GBq
  • (no location specified)
Jul 12, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Acapatamab, Enzalutamide, Abiraterone)

Active, not recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Birmingham, Alabama
  • +13 more
Jun 20, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • Miami, Florida
  • +6 more
Jun 13, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (TQB3823 tablets, Abiraterone acetate tablets, prednisone acetate

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • TQB3823 tablets
  • +2 more
  • Chongqing, Chongqing, China
  • +4 more
Jun 1, 2022

Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco (FOR46, Enzalutamide, Pegfilgrastim)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Prostate Cancer
  • FOR46
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jun 1, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide ([Lu-177]-PNT2002, Abiraterone, Enzalutamide)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Tucson, Arizona
  • +47 more
Jun 1, 2022

Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • XmAb20717 + carboplatin + cabazitaxel
  • +2 more
  • Duarte, California
  • +9 more
May 24, 2022

Metastatic Castration-resistant Prostate Cancer Trial in La Jolla (Cirmtuzumab)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • La Jolla, California
    University of California San Diego
May 22, 2022

Metastatic Castration-resistant Prostate Cancer Trial in United States (FT-7051)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Scottsdale, Arizona
  • +7 more
May 12, 2022

Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Baltimore

Recruiting
  • Prostate Cancer
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins Hospital
May 6, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Beijing (1.11GBq of 177Lu-EB-PSMA-617, 2.00 GBq of 177Lu-EB-PSMA-617,

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • 1.11GBq of 177Lu-EB-PSMA-617
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 6, 2022

Metastatic Castration-resistant Prostate Cancer, Metastatic Breast Cancer Trial in Worldwide (Abiraterone acetate, Prednisone)

Completed
Has Results
  • Metastatic Castration-resistant Prostate Cancer
  • Metastatic Breast Cancer
  • Aurora, Colorado
  • +21 more
Apr 20, 2022

Metastatic Castration-resistant Prostate Cancer Trial in Australia (HP518 - Dose Escalation, HP518 - Dose expansion)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 - Dose expansion
  • Albury, New South Wales, Australia
  • +4 more
May 5, 2022